MK-3009
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for MK-3009, covering 2011-06-15 to 2021-03-30. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Efficacy, and Pharmacokinetics (PK) of Daptomycin (MK-3009) in Japanese Pediatric Subjects With Complicated Skin and Soft Tissue Infections (cSSTI) and Bacteremia (MK-3009-029) [Phase 2]